| |
| |
|
| Insider
Information: |
Young Jonathan |
| Relationship: |
|
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
258,306 |
|
|
Indirect Shares
|
60,000 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
318,306 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Akero Therapeutics, Inc. |
AKRO |
|
2024-05-01 |
258,306 |
2024-05-01 |
60,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AKRO |
Akero Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2024-05-01 |
4 |
AS |
$20.15 |
$100,750 |
D/D |
(5,000) |
258,306 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2024-04-01 |
4 |
AS |
$24.33 |
$121,913 |
D/D |
(5,000) |
263,306 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2024-03-13 |
4 |
S |
$28.33 |
$18,443 |
D/D |
(651) |
268,306 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2024-03-01 |
4 |
OE |
$0.62 |
$51,242 |
D/D |
83,321 |
268,957 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2023-12-27 |
4 |
OE |
$6.36 |
$34,433 |
D/D |
5,414 |
190,545 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2023-12-27 |
4 |
S |
$24.00 |
$129,936 |
D/D |
(5,414) |
185,131 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2023-12-14 |
4 |
S |
$20.76 |
$11,273 |
D/D |
(543) |
185,131 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2023-12-08 |
4 |
A |
$0.00 |
$0 |
D/D |
32,497 |
185,674 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2023-11-17 |
4 |
S |
$14.68 |
$440,259 |
D/D |
(30,000) |
153,177 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2023-10-02 |
4 |
OE |
$21.10 |
$10,339 |
D/D |
490 |
183,667 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2023-10-02 |
4 |
AS |
$51.10 |
$25,039 |
D/D |
(490) |
183,177 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2023-09-13 |
4 |
AS |
$50.34 |
$28,291 |
D/D |
(562) |
183,177 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2023-06-13 |
4 |
AS |
$55.16 |
$29,676 |
D/D |
(538) |
183,739 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2023-03-10 |
4 |
D |
$43.47 |
$27,560 |
D/D |
(634) |
184,277 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2023-01-03 |
4 |
AS |
$54.64 |
$479,560 |
D/D |
(8,777) |
184,911 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2023-01-03 |
4 |
OE |
$0.62 |
$5,398 |
D/D |
8,777 |
193,688 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2022-12-27 |
4 |
AS |
$49.57 |
$619,609 |
D/D |
(12,500) |
182,449 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2022-12-27 |
4 |
OE |
$0.62 |
$75,352 |
D/D |
12,500 |
194,949 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2022-12-09 |
4 |
A |
$0.00 |
$0 |
D/D |
19,195 |
182,449 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2022-10-25 |
4 |
AS |
$44.72 |
$558,944 |
D/D |
(12,500) |
163,254 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2022-10-25 |
4 |
OE |
$6.36 |
$79,500 |
D/D |
12,500 |
175,754 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2022-01-07 |
4 |
OE |
$0.62 |
$17,063 |
D/D |
27,744 |
163,254 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2021-11-04 |
4 |
AS |
$24.33 |
$151,333 |
D/D |
(6,220) |
135,510 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2021-11-03 |
4 |
AS |
$24.27 |
$455,791 |
D/D |
(18,780) |
141,730 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2021-09-01 |
4 |
AS |
$24.04 |
$300,500 |
D/D |
(12,500) |
160,510 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
